AstraZeneca have agreed to supply covid vaccine of 400mn of dosage
AstraZeneca Plc said on Saturday it signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker’s latest deal to pledge its drug to help combat the pandemic.
The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said, adding that it was looking to expand manufacturing of the vaccine, which it said it would provide for no profit during the pandemic.
The deal is the first contract signed by Europe’s Inclusive Vaccines Alliance (IVA), a group formed by France, Germany, Italy and the Netherlands to secure vaccine doses for all member states as soon as possible.
At a meeting of EU Health Ministers on Friday, IVA agreed to merge its activities with those of the EU Commission, Germany’s Health Ministry said.
The deal will add a further 100 million doses to the 2 billion already committed by the group, an AstroZeneca spokesman said.
The experimentation phase of the vaccine is already advanced and is expected to end in the autumn, Italian Health Minister Roberto Speranza said in a Facebook post.
There are no approved vaccines or treatments for COVID-19, the highly contagious respiratory illness caused by the novel coronavirus.
“Many countries in the world have already secured vaccines, Europe has not yet. The rapid coordinated action of a group of member states will create added value for all EU citizens in this crisis,” Spahn said.
It has agreed manufacturing deals globally to meet its target of producing 2 billion doses of the vaccine, including with two ventures backed by Bill Gates and a $1.2 billion agreement with the U.S. government.